Distinction between autoimmune and nonautoimmune hyperthyroidism by determination of thyrotropin-receptor antibodies in patients with the scintigraphic diagnosis of disseminated autonomy.

p53 stability by Mdm2. Nature 387:299–303. 8. Haupt Y, Maya R, Kazaz A, Oren M 1997 Mdm2 promotes the rapid degradation of p53. Nature 387:296–299. 9. Honda R, Yasuda H 1977 Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420:25– 27. 10. Farid NR 1996 Molecular pathogenesis of thyroid carcinoma: The significance of oncogenes, tumor suppressor genes, and genomic instability. Exp Clin Endocrinol & Diab 104(Suppl 4):1–12. 11. Boros P, Juhasz F, Szegedi G, Kraszits E, Stenszky V, Farid NR 1989 Immunogenetic and immunologic studies of differentiated thyroid carcinoma. Cancer 63:1318–1326. 12. Geng Y, Yu Q, Sicinska E, Das M, Bronson RT, Sicinski P 2001 Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc Natl Acad Sci USA 98:194–199. 13. Peerer DS, Upton TM, Ladha MH, Neuman E, Zalivde J, Bernards R, De Caprio JA, Ewen ME 1997 Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177–181. Y. Shi1 M. Zou1 E. Varkondi2 A. Nagy3 L. Kozma2 Nadir R. Farid4